期刊文献+

局部注射平阳霉素和确炎舒松A治疗小儿皮肤血管瘤的比较研究 被引量:3

Comparison of the effects of intralesional bleomycin and triamcinolone acetonide in treatment of cutaneous hemangioma in children
下载PDF
导出
摘要 目的 : 探讨和比较平阳霉素和确炎舒松A治疗小儿皮肤血管瘤的疗效。方法 :  2 80例皮肤血管瘤患儿随机分为平阳霉素治疗组 (10 4例 )和确炎舒松A治疗组 (176例 ) ,平阳霉素组采用平阳霉素瘤体内注射 ,浓度为 2~ 3.2mg ml ;确炎舒松A组采用确炎舒松A瘤体内注射 ,浓度为 8mg ml。每 2周重复注射一次 ,总疗程 3~ 10次。结果 : 平阳霉素组 10 4例患儿中 ,治愈 89例 (治愈率 85 .6 % )和有效 15例 (14 .4 % ) ,确炎舒松A组 176例血管瘤患儿中 ,治愈 86例 (4 8.9% )和有效 75例 (4 2 .6 % )。两组比较差异有统计学意义 (P <0 .0 0 1)。结论 : 平阳霉素瘤体内注射治疗小儿皮肤血管瘤安全有效 ,其疗效优于确炎舒松A。 Objective: To compare the effects of bleomycin and triamcinolone acetonide in the treatment of cutaneous hemangioma in children. Methods: Two hundreds and eighty children, aged 3 months to 6 years, with cutaneous hemangioma (80 capillary, 47 cavernous and 153 mixed) were divided into two groups. One hundred and four children were treated with intralesional bleomycin (2~3.2 mg/ml) injections and 176 children were treated with intralesional triamcinolone acetonide (8 mg/ml) injections. The injections were repeated every other week for a total of 3~10 times. Results: The cure rate and response rate in the bleomycin group were 85.6% (89/104) and 14.4% (15/104), respectively. The cure rate and response rate in triamcinolone group were 48.9% (86/176) and 42.6% (75/176), respectively. There was a significant difference in effectiveness of treatment of cutaneous hemangioma between the two groups (P<0.001). The side effects included fever (12 cases) and local necrosis (4 cases) in bleomycin group and temporary local subcutaneous fat atrophy (23 cases) and Cushing syndrome (8 cases) in triamcinolone group. Conclusion: Bleomycin sclerotherpy in the treament of cutaneous hemangioma of children was very effective, simple and safe. It is better than the triamcinolone acetonide sclerotherpy.
出处 《中国麻风皮肤病杂志》 北大核心 2004年第2期130-131,共2页 China Journal of Leprosy and Skin Diseases
关键词 局部注射 平阳霉素 确炎舒松A 药物治疗 小儿 皮肤血管瘤 cutaneous hemangioma bleomycin triamcinolone acetonide
  • 相关文献

参考文献5

二级参考文献36

  • 1贾暮云,金志勤,唐友盛,樊功为,尚伟.平阳霉素治疗颌面部海绵状血管瘤24例临床报告[J].中华口腔医学杂志,1994,29(5):294-296. 被引量:89
  • 2赵福运,曾祥辉,孙开华,吴菲,孔庆芬.口腔颌面部血管瘤和血管畸形[J].中华口腔医学杂志,1994,29(2):88-90. 被引量:47
  • 3陈钟英 刘天培 等.临床药物手册,第3版[M].上海:上海科技出版社,1995.356.
  • 4Liekens S, Verbeken E, Vandeputte M, et al. A Novel Animal Model for Hemangioma: Inhibitor of hemangioma development by the Angiogenesis Inhibitor TNP-470 [J]. Cancer Res, 1999,15(10) :2376-2383.
  • 5Takahashi K, . Mulliken JB, Kozakewich HPW, et al. Cellular Markers That Distinguish the Phases of hemangioma during Infancy and Childhood[J]. J Clin Invest, 1994,93:2357-2364.
  • 6Tan ST,Hasan Q, Velickovic M, et al. A novel in vitro human model of hemangioma[ J]. Mod Pathol,2000,13 ( 1 ) :92-99.
  • 7Dosanjh A, Chang J, Bresnick S, et al. In vitro characteristics of neonatal hemangioma endothelial cells: similaries and difference between normal neonatal and fetal endothelial cells [ J ]. J Cutan Pathol,2000,27 (9) :441-450.
  • 8Chang J, Most D, Bresnick B, et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis [J]. Plast Reconstr Surg, 1999,103 (1): 1-9.
  • 9Sgonc R, Fuerhapter C, Boeck G, et al. Induction of apoptosis in human dermal microvascular endothelial cells and infantile hemangiomas by interferon-alpha[J]. Int Arch Allergy Immunol,1998,117(3) :209-214.
  • 10Razon MJ, Kraling BM, Mu[liken JB, et al. Increased apoptosis with onset of involution in infantile hemangioma[J]. Microcirculation, 1998,5:189-195.

共引文献55

同被引文献21

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部